Latigo Biotherapeutics is appointing Neha Krishnamohan as both Chief Financial Officer (CFO) and Chief Business Officer (CBO). Latigo is a clinical-stage biopharmaceutical company that innovates to develop non-opioid pain medicines. Krishnamohan Responds to Appointment In comments in a press release, Krishnamohan emphasized Latigo’s mission—to stop pain transmission without risk of addiction. “I am honored and energized to join the team at Latigo at a pivotal time for the company,” K...